Biosense Webster, Inc. Sustainability Profile
Biosense Webster, Inc., a subsidiary of Johnson & Johnson MedTech, is a leading innovator in the field of electrophysiology, headquartered in the United States. Established in 1996, the company has made significant strides in advancing cardiac mapping and ablation technologies, catering to healthcare professionals worldwide. With a strong presence in North America, Europe, and Asia, Biosense Webster focuses on developing cutting-edge products and services that enhance the diagnosis and treatment of arrhythmias. Their flagship offerings, including the CARTO® 3 System and the THERMOCOOL® Catheter, are renowned for their precision and efficacy, setting industry standards. Recognised for its commitment to improving patient outcomes, Biosense Webster continues to solidify its market position through innovation and collaboration, making it a trusted name in the electrophysiology sector.
DitchCarbon Score
How does Biosense Webster, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biosense Webster, Inc.'s score of 78 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Biosense Webster, Inc., headquartered in the US, currently does not have specific carbon emissions data available for recent years. As a current subsidiary of Johnson & Johnson, any climate commitments or emissions data would be inherited from its parent company. Johnson & Johnson has established various climate initiatives, including Science-Based Targets Initiative (SBTi) commitments, which aim to significantly reduce greenhouse gas emissions across its operations. However, specific reduction targets or achievements for Biosense Webster, Inc. are not detailed in the available information. The company is part of a broader corporate family that is actively engaged in sustainability efforts, including commitments to renewable energy and emissions reduction strategies. As such, while direct emissions data for Biosense Webster, Inc. is not provided, it aligns with the climate goals set forth by Johnson & Johnson, which include comprehensive strategies to address Scope 1, 2, and 3 emissions. In summary, while specific emissions figures and reduction targets for Biosense Webster, Inc. are not available, the company is positioned within a framework of climate commitments driven by its parent organisation, Johnson & Johnson.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 1990 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 308,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 751,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | - | - | - | - | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | - | - | - | - | 00,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
How Carbon Intensive is Biosense Webster, Inc.'s Industry?
How Carbon Intensive is Biosense Webster, Inc.'s Location?
Biosense Webster, Inc.'s Scope 3 Categories Breakdown
Biosense Webster, Inc.'s Scope 3 emissions, which decreased by 2% last year and increased significantly since 2011, demonstrating supply chain emissions tracking. The vast majority of their carbon footprint comes from suppliers and value chain emissions, representing the vast majority of total emissions under the GHG Protocol, with "Purchased Goods and Services" being the largest emissions source at 72% of Scope 3 emissions.
Top Scope 3 Categories
Biosense Webster, Inc.'s Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Biosense Webster, Inc. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
